Related Experiment Video
Updated: Aug 7, 2026
06:30
Intraductal Delivery to the Rabbit Mammary Gland
Published on: March 9, 2017
Inflammatory breast cancer: current concepts in local management
Ian J Bristol1, Thomas A Buchholz
1Department of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA.
Breast Disease
|June 10, 2006
Summary
Inflammatory breast cancer (IBC) management has advanced significantly. A combined approach of chemotherapy, mastectomy, and radiation improves local control rates to 70-80%, enhancing survival for patients with this aggressive cancer.
Area of Science:
- Oncology
- Breast Cancer Research
- Radiation Oncology
Background:
- Inflammatory breast cancer (IBC) is a highly aggressive carcinoma with rapid progression and early metastasis.
- Despite its aggressiveness, most IBC patients present with localized disease.
- Survival has improved due to doxorubicin-based chemotherapy, highlighting the importance of local management.
Purpose of the Study:
- To review advances in the locoregional management of Inflammatory breast cancer.
- To analyze literature on local treatment options for IBC.
- To provide evidence-based recommendations for oncologists managing IBC.
Main Methods:
- Review of relevant literature on locoregional treatment options for IBC.
- Analysis of treatment techniques and outcomes.
- Synthesis of evidence for treatment recommendations.
Main Results:
- Combined-modality treatment (neoadjuvant chemotherapy, mastectomy, adjuvant chemotherapy, and radiation) has improved local control rates from <50% to 70-80%.
- Chemotherapy response correlates with higher 5-year local control rates.
- Improvements in local control have led to better patient survival.
Conclusions:
- Locoregional management is a critical component of curative treatment for IBC.
- Combined-modality therapy has transformed IBC outcomes.
- Evidence-based recommendations are crucial for optimizing IBC patient care.
